Maftivimab

Maftivimab is a Zaire ebolavirus glycoprotein-directed human monoclonal antibody that is part of the fixed-dose combination atoltivimab/maftivimab/odesivimab that is used for the treatment of Zaire ebolavirus (Ebola virus).^[1][2]

Maftivimab

Monoclonal antibody
Type	Whole antibody
Source	Human
Target	Zaire ebolavirus glycoprotein
Clinical data
Pronunciation	maf tiv' i mab
License data	US DailyMed: Maftivimab
Drug class	Monoclonal antibody
ATC code	None
Identifiers
CAS Number	2135632-36-7
UNII	KOP95331M4
KEGG	D11450
Chemical and physical data
Formula	C6368H9886N1706O2008S46
Molar mass	143947.83 g·mol−1